Patients with suspected new bladder cancer were randomly assigned 1:1 to transurethral resection of bladder tumor or ...
Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name ...
Prof James Catto from the University of Sheffield described the findings as a "major breakthrough" in treating bladder cancer ...
The Independent on MSN5d
‘Game changer’ immunotherapy drug could lead to increased survival rates for bladder cancer patientsThe study found that patients with muscle-invasive bladder cancer had significantly less risk of cancer progressing or ...
StarsInsider on MSN3d
Bladder cancer: the signs, symptoms, and treatmentsBladder cancer is among the top 10 most common cancer types in the world, with approximately 573,000 new cases annually. Men ...
Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research suggests that initial MRI imaging and biopsy could be used to reduce the time ...
They were used on five patients, and four of them are now either in remission or cancer-free. Read more at straitstimes.com.
Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research ...
BladderPath trial found that patients with suspected invasive bladder cancer undergoing initial mpMRI were treated faster ...
J&J acquired rights to TAR-200 when it bought privately-owned biotech Taris for an undisclosed sum in 2019, and has big sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback